ROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL BREAST CANCER
Hormone therapy with tamoxifen is the commonly used treatment for luminal breast cancer. However, it appears to be ineffective in 20–40 % of cases and the possible reasons of this failure are related to the features of distribution and structure of estrogen receptor alpha (ERα) in tumor tissue. Real...
Saved in:
| Main Authors: | Е. М. Slonimskaya, S. V. Vtorushin, N. N. Babyshkina, S. V. Patalyak |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2016-02-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/50 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ROR1 and BMI-1 proteins as potential predictors of the effectiveness of hormone therapy in luminal breast cancer
by: V. O. Tarakanova, et al.
Published: (2022-06-01) -
MORPHOLOGICAL STUDY OF LUMINAL BREAST CANCER
by: M. V. Zavyalova, et al.
Published: (2016-02-01) -
Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
by: T. A. Dronova, et al.
Published: (2018-11-01) -
LYMPHOGENIC METASTASIS IN LUMINAL-TYPE A BREASR CANCER
by: M. V. Zavjalova, et al.
Published: (2016-02-01) -
ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE
by: N. N. Babyshkina, et al.
Published: (2017-06-01)